ProCE Banner Activity

Exploring New Diagnostic and Therapeutic Possibilities in Chronic Spontaneous Urticaria

Slideset Download

Download these slides for an expert review of the diagnosis and treatment, including current and promising investigational therapies, for chronic spontaneous urticaria.

Released: September 09, 2022

Expiration: September 08, 2023

Begin Activity

Share

Faculty

Jonathan Bernstein

Jonathan Bernstein, MD

Professor of Medicine
Division of Immunology, Rheumatology, and Allergy
Department of Internal Medicine
University of Cincinnati
Cincinnati, Ohio

Acknowledgement

This program is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc.; Incyte Corporation; Novartis Pharmaceuticals Corporation; and Sanofi and Regeneron Pharmaceuticals.

Disclosure

Jonathan A. Bernstein, MD: consultant/advisor/speaker: AstraZeneca, Genentech, Novartis, Sanofi/Regeneron; researcher: Allakos, Amgen, AstraZeneca, Celldex, Genentech, Sanofi/Regeneron, TLL

Additional Information

Program Medium

This program has been made available online.